Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: State of the art

Domenico Albano, Alberto Bruno, Caterina Patti, Giuseppe Micci, Massimo Midiri, Corrado Tarella, Massimo Galia

Research output: Contribution to journalReview article

Abstract

The improvements in magnetic resonance imaging (MRI) technology and the concern related to the increased cancer risk in patients with lymphoma, also due to radiation exposure associated with imaging examinations, have led to the introduction of whole-body MRI (WB-MRI) as a radiation-free alternative to standard imaging procedures. WB-MRI seems a less histology-dependent functional imaging test than 18 F-fluorodeoxyglucose-positron emission tomography/CT (18 F-FDG-PET/CT). In patients with FDG-avid lymphomas, such as diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL), 18 F-FDG-PET/CT remains the imaging reference standard for staging, with WB-MRI potentially being a complementary modality that could replace CT, especially in young patients. On the other hand, WB-MRI is a valuable imaging procedure for lymphoma surveillance and in lymphomas with variable/low FDG avidity and nonfollicular indolent lymphomas. The aim of this paper is to discuss the current state of the art of WB-MRI in lymphoma by evaluating its diagnostic performance in different lymphoma subtypes: Hodgkin, aggressive, and indolent lymphomas.

Original languageEnglish
JournalHematological Oncology
DOIs
Publication statusE-pub ahead of print - Sep 5 2019

Fingerprint

Lymphoma
Magnetic Resonance Imaging
Hodgkin Disease
Lymphoma, Large B-Cell, Diffuse
Fluorodeoxyglucose F18
Positron-Emission Tomography
Histology
Radiation
Technology
Neoplasms

Cite this

Whole-body magnetic resonance imaging (WB-MRI) in lymphoma : State of the art. / Albano, Domenico; Bruno, Alberto; Patti, Caterina; Micci, Giuseppe; Midiri, Massimo; Tarella, Corrado; Galia, Massimo.

In: Hematological Oncology, 05.09.2019.

Research output: Contribution to journalReview article

Albano, Domenico ; Bruno, Alberto ; Patti, Caterina ; Micci, Giuseppe ; Midiri, Massimo ; Tarella, Corrado ; Galia, Massimo. / Whole-body magnetic resonance imaging (WB-MRI) in lymphoma : State of the art. In: Hematological Oncology. 2019.
@article{166a1aed9640489caf6e39bdc6347dcb,
title = "Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: State of the art",
abstract = "The improvements in magnetic resonance imaging (MRI) technology and the concern related to the increased cancer risk in patients with lymphoma, also due to radiation exposure associated with imaging examinations, have led to the introduction of whole-body MRI (WB-MRI) as a radiation-free alternative to standard imaging procedures. WB-MRI seems a less histology-dependent functional imaging test than 18 F-fluorodeoxyglucose-positron emission tomography/CT (18 F-FDG-PET/CT). In patients with FDG-avid lymphomas, such as diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL), 18 F-FDG-PET/CT remains the imaging reference standard for staging, with WB-MRI potentially being a complementary modality that could replace CT, especially in young patients. On the other hand, WB-MRI is a valuable imaging procedure for lymphoma surveillance and in lymphomas with variable/low FDG avidity and nonfollicular indolent lymphomas. The aim of this paper is to discuss the current state of the art of WB-MRI in lymphoma by evaluating its diagnostic performance in different lymphoma subtypes: Hodgkin, aggressive, and indolent lymphomas.",
author = "Domenico Albano and Alberto Bruno and Caterina Patti and Giuseppe Micci and Massimo Midiri and Corrado Tarella and Massimo Galia",
note = "{\circledC} 2019 John Wiley & Sons, Ltd.",
year = "2019",
month = "9",
day = "5",
doi = "10.1002/hon.2676",
language = "English",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",

}

TY - JOUR

T1 - Whole-body magnetic resonance imaging (WB-MRI) in lymphoma

T2 - State of the art

AU - Albano, Domenico

AU - Bruno, Alberto

AU - Patti, Caterina

AU - Micci, Giuseppe

AU - Midiri, Massimo

AU - Tarella, Corrado

AU - Galia, Massimo

N1 - © 2019 John Wiley & Sons, Ltd.

PY - 2019/9/5

Y1 - 2019/9/5

N2 - The improvements in magnetic resonance imaging (MRI) technology and the concern related to the increased cancer risk in patients with lymphoma, also due to radiation exposure associated with imaging examinations, have led to the introduction of whole-body MRI (WB-MRI) as a radiation-free alternative to standard imaging procedures. WB-MRI seems a less histology-dependent functional imaging test than 18 F-fluorodeoxyglucose-positron emission tomography/CT (18 F-FDG-PET/CT). In patients with FDG-avid lymphomas, such as diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL), 18 F-FDG-PET/CT remains the imaging reference standard for staging, with WB-MRI potentially being a complementary modality that could replace CT, especially in young patients. On the other hand, WB-MRI is a valuable imaging procedure for lymphoma surveillance and in lymphomas with variable/low FDG avidity and nonfollicular indolent lymphomas. The aim of this paper is to discuss the current state of the art of WB-MRI in lymphoma by evaluating its diagnostic performance in different lymphoma subtypes: Hodgkin, aggressive, and indolent lymphomas.

AB - The improvements in magnetic resonance imaging (MRI) technology and the concern related to the increased cancer risk in patients with lymphoma, also due to radiation exposure associated with imaging examinations, have led to the introduction of whole-body MRI (WB-MRI) as a radiation-free alternative to standard imaging procedures. WB-MRI seems a less histology-dependent functional imaging test than 18 F-fluorodeoxyglucose-positron emission tomography/CT (18 F-FDG-PET/CT). In patients with FDG-avid lymphomas, such as diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL), 18 F-FDG-PET/CT remains the imaging reference standard for staging, with WB-MRI potentially being a complementary modality that could replace CT, especially in young patients. On the other hand, WB-MRI is a valuable imaging procedure for lymphoma surveillance and in lymphomas with variable/low FDG avidity and nonfollicular indolent lymphomas. The aim of this paper is to discuss the current state of the art of WB-MRI in lymphoma by evaluating its diagnostic performance in different lymphoma subtypes: Hodgkin, aggressive, and indolent lymphomas.

U2 - 10.1002/hon.2676

DO - 10.1002/hon.2676

M3 - Review article

C2 - 31486520

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

ER -